- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Artificial Intelligence and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Elisabeth Kohoutek
Events 23 results
Speaking Engagement
November 16, 2023
Elisabeth Kohoutek to Speak at ZKNFT Spezial 2023
Conference
November 7, 2023
Pharmaceutical University 2023
Speaking Engagement
October 24, 2023
Elisabeth Kohoutek to Speak at Preventure 2023
Webinar
October 10, 2023
Key Food and Beverage Issues: Recent Developments in False Advertising Litigation in the U.S and the European Union
Conference
September 12, 2023
Talk im Turm: German Supply Chain Due Diligence Act – not relevant for real estate holders and managers?!
Speaking Engagement
September 7, 2023
Elisabeth Kohoutek to Speak at Health Insurance Hack&Con 2023
Webinar
May 10, 2023
Talk im Turm – Parallel Import: ECJ Reboxing vs. Relabeling Decision
Webinar
March 13, 2023
Key Food and Beverage Issues: Challenges and Opportunities in 2023
Speaking Engagement
December 16, 2022
Ulf Grundmann, Elisabeth Kohoutek to Speak at Hebrew University of Jerusalem’s BioMED MBA Program
Webinar
November 9, 2022
Talk im Turm – German Whistleblower Protection Act and Supply Chain Due Diligence Obligations
Conference
November 1, 2022
Pharmaceutical University 2022